These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 30312482

  • 1. The efficacy of extracorporeal photopheresis to arrest bronchiolitis obliterans in lung allograft recipients was compared between two automated photopheresis instruments.
    Chionis L, Grossman BJ, Hachem R, Commean P, Derfler MC, Vedantham S, Dodds K, Spitznagel E, Atkinson J, Despotis G.
    Transfusion; 2018 Dec; 58(12):2933-2941. PubMed ID: 30312482
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Linear relationship between lymphocyte counts in peripheral blood and buffy coat collected during extracorporeal photopheresis.
    Liu C, Shah K, Dynis M, Eby CS, Grossman BJ.
    Transfusion; 2013 Nov; 53(11):2635-43. PubMed ID: 23414109
    [Abstract] [Full Text] [Related]

  • 4. Extracorporeal photopheresis performed on the CELLEX® compared with the UVAR-XTS® instrument is more efficient and better tolerated in children with steroid-refractory graft-versus-host disease.
    Kapadia E, Wong E, Perez-Albuerne E, Jacobsohn D.
    Pediatr Blood Cancer; 2015 Aug; 62(8):1485-8. PubMed ID: 25881179
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Factors Associated With Mortality and Response to Extracorporeal Photopheresis in Lung Allograft Recipients With Bronchiolitis Obliterans Syndrome.
    Karnes HE, Schindler EI, Morrell M, Hachem RR, Berman K, Vedantham S, Atkinson J, Spitznagel E, Despotis GJ.
    Transplantation; 2019 May; 103(5):1036-1042. PubMed ID: 30130331
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the CELLEX™ and UVAR-XTS™ closed-system extracorporeal photopheresis devices in the treatment of chronic graft-versus-host disease.
    Whittle RM, Denney H, Chantry AD, Alfred A, Taylor PC.
    J Clin Apher; 2017 Dec; 32(6):462-473. PubMed ID: 28608529
    [Abstract] [Full Text] [Related]

  • 8. Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction.
    EPI Study Group, Hage CA, Klesney-Tait J, Wille K, Arcasoy S, Yung G, Hertz M, Chan KM, Morrell M, Goldberg H, Vedantham S, Derfler MC, Commean P, Berman K, Spitznagel E, Atkinson J, Despotis G.
    Transfus Med; 2021 Aug; 31(4):292-302. PubMed ID: 33955079
    [Abstract] [Full Text] [Related]

  • 9. Extracorporeal photopheresis for graft versus host disease: Identifying a clinical pathway and associated resource utilization.
    Yerrabothala S, Talebian L, Klinker K, Hickman J, Hill JM, Hayes C, Lowrey C, Szczepiorkowski ZM, Meehan KR.
    J Clin Apher; 2018 Jun; 33(3):310-315. PubMed ID: 29193271
    [Abstract] [Full Text] [Related]

  • 10. Lung transplant recipients on long-term extracorporeal photopheresis.
    Isenring B, Robinson C, Buergi U, Schuurmans MM, Kohler M, Huber LC, Benden C.
    Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28653398
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cessation of extracorporeal photopheresis in chronic lung allograft dysfunction: effects on clinical outcome in adults.
    Robinson CA, Huber L, Murer C, Schuurmans M, Kohler M, Hofbauer G, Benden C.
    Swiss Med Wkly; 2017 Oct; 147():w14429. PubMed ID: 28488260
    [Abstract] [Full Text] [Related]

  • 13. A prospective interventional study on the use of extracorporeal photopheresis in patients with bronchiolitis obliterans syndrome after lung transplantation.
    Jaksch P, Scheed A, Keplinger M, Ernst MB, Dani T, Just U, Nahavandi H, Klepetko W, Knobler R.
    J Heart Lung Transplant; 2012 Sep; 31(9):950-7. PubMed ID: 22884382
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
    Benden C, Haughton M, Leonard S, Huber LC.
    J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.